Nordenström Erik, Westerdahl Johan, Lindergård Birger, Lindblom Pia, Bergenfelz Anders
Department of Surgery, Lund University Hospital, S-221 85 Lund, Sweden.
World J Surg. 2002 Dec;26(12):1463-7. doi: 10.1007/s00268-002-6433-2. Epub 2002 Sep 26.
Primary hyperparathyroidism (pHPT) is associated with an increased fracture risk, and decreased bone density thus has been considered an indication for surgery. However, many pHPT patients have a multifactorial risk profile for osteoporosis and bone fractures. The aim of the present study was to evaluate variables associated with fracture risk within the group of pHPT patients. A series of 203 consecutive patients operated for pHPT were investigated with bone mineral content and biochemical and clinical risk factors for bone fracture. Seventeen patients (8%) had a history of at least one bone fracture up to 5 years before pHPT surgery. Twenty-six patients (13%) had a history of at least one fracture during the 10-year period prior to surgery. In the univariate analyses corticosteroid treatment, serum levels of alkaline phosphatase, 25-hydroxyvitamin D3, type I collagen telopeptide, and bone mineral content were found to be associated with a history of bone fractures up to 10 years before surgery. Additionally, age and menopausal status were of importance for fractures during the 10-year-period, whereas a history of cardiovascular disease was important for fractures during the 5-year-period prior to surgery. Multivariate analyses showed that serum level of PTH was independently associated with bone fractures during the 5-year period prior to pHPT surgery and further that serum level of 25-hydroxyvitamin D3 was associated with fractures up to 10 years before surgery. In conclusion, serum levels of 25-hydroxyvitamin D3 and PTH were independently associated with a history of bone fractures in pHPT. These variables should be considered when evaluating patients for parathyroid surgery.
原发性甲状旁腺功能亢进症(pHPT)与骨折风险增加相关,骨密度降低因此被视为手术指征。然而,许多pHPT患者存在骨质疏松和骨折的多因素风险状况。本研究的目的是评估pHPT患者组中与骨折风险相关的变量。对连续203例接受pHPT手术的患者进行了骨矿物质含量以及骨折的生化和临床风险因素调查。17例患者(8%)在pHPT手术前5年内有至少一次骨折史。26例患者(13%)在手术前10年内有至少一次骨折史。单因素分析发现,皮质类固醇治疗、血清碱性磷酸酶水平、25-羟基维生素D3、I型胶原端肽和骨矿物质含量与手术前10年内的骨折史相关。此外,年龄和绝经状态对10年内的骨折很重要,而心血管疾病史对手术前5年内的骨折很重要。多因素分析表明,血清甲状旁腺激素(PTH)水平与pHPT手术前5年内的骨折独立相关,此外,血清25-羟基维生素D3水平与手术前10年内的骨折相关。总之,血清25-羟基维生素D3和PTH水平与pHPT患者的骨折史独立相关。在评估甲状旁腺手术患者时应考虑这些变量。